Full Press Release Details
LEIDEN, The Netherlands , Aug. 24, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR ) announces that Pharming's management will participate in the following investor conferences in the U.S. in the month of September:
• 2023 Wells Fargo Healthcare Conference, Boston , September 6-8 Sijmen de Vries, Chief Executive Officer, and Michael Levitan, VP Investor Relations and Corporate Communications, will participate in a fireside chat question and answer session on Thursday, September 7 at 16:30 ET / 22:30 CET . A live webcast and replay of the fireside chat will be available in the "Upcoming Events" and "News" sections of Pharming's website.
• H.C. Wainwright 25 th Annual Global Investment Conference, New York , September 11-13 Sijmen de Vries, Chief Executive Officer, will present on Wednesday, September 13 at 08:30 ET / 14:30 CET . A live webcast and replay of the presentation will be available in the "Upcoming Events" and "News" sections of Pharming's website.
• 2023 Cantor Global Healthcare Conference, New York , September 26-28 Michael Levitan, VP Investor Relations and Corporate Communications, will present on Thursday, September 28 at 10:20 ET / 16:20 CET .
For more information about these conferences, or to schedule a one-to-one meeting with Pharming's management team, please contact Pharming's Investor Relations team at [email protected] or your Wells Fargo, H.C. Wainwright or Cantor representative.
About Pharming Group N.V.
Pharming Group N.V. (Euronext Amsterdam: PHARM/Nasdaq: PHAR ) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands , and has employees around the globe who serve patients in over 30 markets in North America , Europe , the Middle East , Africa , and Asia-Pacific .
For more information, visit www.pharming.com and find us on LinkedIn .
For further public information, contact:
Pharming Group, Leiden, The Netherlands Michael Levitan, VP Investor Relations & Corporate Communications T: +1 (908) 705 1696
Heather Robertson , Investor Relations & Corporate Communications Manager E: [email protected]